MOHAMED AHMED AHMED
MASHAL
INVESTIGADOR/A DOCTOR/A
Publications (20) MOHAMED AHMED AHMED MASHAL publications
2024
-
Comparative analysis of lipid-peptide nanoparticles prepared via microfluidics, reverse phase evaporation, and ouzo techniques for efficient plasmid DNA delivery
European Journal of Pharmaceutics and Biopharmaceutics, Vol. 201
-
Expanding the horizon of transient CAR T therapeutics using virus-free technology
Biotechnology Advances, Vol. 72
2023
-
Bektore ez-biral lipidikoak garatzeko erabiltzen diren teknikak eta hauen garrantzia etorkizunerako
Osasun zientziak: V. Ikergazte Nazioarteko Ikerteta Euskaraz. 2023eko maitzaren 17, 18 eta 19 Donostia, Euskal Herria.
-
Stability of polymeric cationic niosomes and their plasmid DNA-based complexes as gene delivery carriers
Drug Delivery, Vol. 30, Núm. 1
-
Stem Cell-Derived Extracellular Vesicles as a Potential Therapeutic Tool for Eye Diseases: From Benchtop to Bedside
Advances in experimental medicine and biology, Vol. 1410, pp. 127-143
2022
-
Cell-based therapy for the treatment of glioblastoma: An update from preclinical to clinical studies
Cells, Vol. 11, Núm. 1
-
The use of cerium oxide nanoparticles in liver disorders: A double-sided coin?
Basic and Clinical Pharmacology and Toxicology, Vol. 130, Núm. 3, pp. 349-363
2021
-
Insights into the potential role of alpha1-antitrypsin in COVID-19 patients: Mechanisms, current update, and future perspectives
Clinical Respiratory Journal
-
Mesenchymal Stem Cells: The Past Present and Future
Advances in Experimental Medicine and Biology (Springer), pp. 107-129
-
Mesenchymal stem cells as a gene delivery tool: Promise, problems, and prospects
Pharmaceutics, Vol. 13, Núm. 6
2019
-
Cationic niosome-based hBMP7 gene transfection of neuronal precursor NT2 cells to reduce the migration of glioma cells in vitro
Journal of Drug Delivery Science and Technology, Vol. 53
-
Cationic niosomes as non-viral vehicles for nucleic acids: Challenges and opportunities in gene delivery
Pharmaceutics, Vol. 11, Núm. 2
-
Gene delivery to the rat retina by non-viral vectors based on chloroquine-containing cationic niosomes
Journal of Controlled Release, Vol. 304, pp. 181-190
2018
-
Gene transfer to rat cerebral cortex mediated by polysorbate 80 and poloxamer 188 nonionic surfactant vesicles
Drug Design, Development and Therapy, Vol. 12, pp. 3937-3949
-
Non-viral vectors based on cationic niosomes as efficient gene delivery vehicles to central nervous system cells into the brain
International Journal of Pharmaceutics, Vol. 552, Núm. 1-2, pp. 48-55
-
Stem cell-based gene delivery mediated by cationic niosomes for bone regeneration
Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 14, Núm. 2, pp. 521-531
2017
-
Retinal gene delivery enhancement by lycopene incorporation into cationic niosomes based on DOTMA and polysorbate 60
Journal of Controlled Release, Vol. 254, pp. 55-64
2016
-
Elaboration and physicochemical characterization of niosome-based nioplexes for gene delivery purposes
Methods in Molecular Biology (Humana Press Inc.), pp. 63-75
2015
-
Protamine/DNA/niosome ternary nonviral vectors for gene delivery to the retina: The role of protamine
Molecular Pharmaceutics, Vol. 12, Núm. 10, pp. 3658-3671
2014
-
A novel cationic niosome formulation for gene delivery to the retina
Journal of Controlled Release, Vol. 174, Núm. 1, pp. 27-36